Zurich Cantonal Bank’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.43M | Buy |
102,129
+58,348
| +133% | +$1.62M | 0.01% | 928 |
|
|
2025
Q4 | $1.21M | Buy |
43,781
+6,354
| +17% | +$162K | ﹤0.01% | 1236 |
|
|
2025
Q3 | $908K | Buy |
37,427
+4,893
| +15% | +$97.3K | ﹤0.01% | 1346 |
|
|
2025
Q2 | $553K | Buy |
32,534
+6,597
| +25% | +$115K | ﹤0.01% | 1596 |
|
|
2025
Q1 | $507K | Buy |
25,937
+3,308
| +15% | +$86.7K | ﹤0.01% | 1591 |
|
|
2024
Q4 | $561K | Buy |
22,629
+1,233
| +6% | +$31.5K | ﹤0.01% | 1562 |
|
|
2024
Q3 | $524K | Buy |
21,396
+516
| +2% | +$13.3K | ﹤0.01% | 1530 |
|
|
2024
Q2 | $489K | Sell |
20,880
-221
| -1% | -$5.43K | ﹤0.01% | 1503 |
|
|
2024
Q1 | $697K | Buy |
21,101
+376
| +2% | +$11.7K | ﹤0.01% | 1270 |
|
|
2023
Q4 | $564K | Buy |
20,725
+8,818
| +74% | +$219K | ﹤0.01% | 1424 |
|
|
2023
Q3 | $286K | Buy |
11,907
+1,549
| +15% | +$41.5K | ﹤0.01% | 1732 |
|
|
2023
Q2 | $331K | Buy |
10,358
+86
| +0.8% | +$2.79K | ﹤0.01% | 1613 |
|
|
2023
Q1 | $315K | Buy |
10,272
+750
| +8% | +$29.6K | ﹤0.01% | 1590 |
|
|
2022
Q4 | $372K | Sell |
9,522
-79
| -0.8% | -$3.54K | ﹤0.01% | 1424 |
|
|
2022
Q3 | $457K | Sell |
9,601
-1,038
| -10% | -$59.2K | ﹤0.01% | 1251 |
|
|
2022
Q2 | $412K | Buy |
10,639
+1,043
| +11% | +$41.5K | ﹤0.01% | 1346 |
|
|
2022
Q1 | $550K | Buy |
9,596
+380
| +4% | +$24.9K | ﹤0.01% | 1286 |
|
|
2021
Q4 | $734K | Buy |
9,216
+1,353
| +17% | +$116K | ﹤0.01% | 1189 |
|
|
2021
Q3 | $684K | Buy |
7,863
+630
| +9% | +$63.3K | ﹤0.01% | 1100 |
|
|
2021
Q2 | $931K | Buy |
7,233
+1,552
| +27% | +$124K | 0.01% | 917 |
|
|
2021
Q1 | $455K | Buy |
5,681
+3,523
| +163% | +$335K | ﹤0.01% | 1290 |
|
|
2020
Q4 | $176K | Buy |
+2,158
| New | +$106K | ﹤0.01% | 1929 |
|
Other funds holding BEAM
AIM
FCM
VPM
AVM
VCM
NAMA
